ERIS

Eris Lifesciences Share Price Eris Lifesciences

₹875.5
7.25 (0.84%)
  • Advice
  • Hold
23 February, 2024 16:56 BSE: 540596 NSE: ERISISIN: INE406M01024

Start SIP in Eris Lifesciences

Start SIP

Eris Lifesciences Performance

Day Range

  • Low 862
  • High 877
₹ 875

52 Week Range

  • Low 551
  • High 972
₹ 875
  • Open Price872
  • Previous Close868
  • Volume61675

Eris Lifesciences Share Price

  • Over 1 Month -1.9%
  • Over 3 Month -7.5%
  • Over 6 Month 3.73%
  • Over 1 Year 39.76%

Eris Lifesciences Key Statistics

P/E Ratio 30.8
PEG Ratio -12.6
Market Cap Cr 11,909
Price to Book Ratio 5.4
EPS 28.9
Dividend 0
Relative Strength Index 44.62
Money Flow Index 39.94
MACD Signal -6.25
Average True Range 33.83
Eris Lifesciences Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 316410411308
Operating Expenses Qtr Cr 250265256203
Operating Profit Qtr Cr 74144156111
Depreciation Qtr Cr 28252017
Interest Qtr Cr 15773
Tax Qtr Cr 32228
Net Profit Qtr Cr 3211811188
IndicatorMar 2023
Total Revenue Annual Cr 1,348
Operating Expenses Annual Cr 826
Operating Profit Annual in Cr 505
Depreciation Cr 65
Interest Annual Cr 21
Tax Annual Cr 39
Net Profit Annual Cr 398
IndicatorMar 2023
Cash from Operating Activity Annual Cr 322
Cash from Investing Activity Annual Cr -513
Cash from Financing Annual Activity Cr 194
Net Cash Flow Annual Cr 3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 2,222
Fixed Assets Annual Cr 898
Total Non Current Assets Annual Cr 2,232
Total Current Assets Annual Cr 552
Total Assets Annual Cr 2,784
IndicatorMar 2023
Book Value Per Share Annual Rs 163
ROE Annual % 18
ROCE Annual % 18
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 39
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 483505467397
Operating Expenses Qtr Cr 311324297284
Operating Profit Qtr Cr 176181170119
Depreciation Qtr Cr 46424135
Interest Qtr Cr 1816179
Tax Qtr Cr 1441914
Net Profit Qtr Cr 1031239565
IndicatorMar 2023
Total Revenue Annual Cr 1,696
Operating Expenses Annual Cr 1,148
Operating Profit Annual in Cr 537
Depreciation Cr 117
Interest Annual Cr 26
Tax Annual Cr 30
Net Profit Annual Cr 382
IndicatorMar 2023
Cash from Operating Activity Annual Cr 292
Cash from Investing Activity Annual Cr -982
Cash from Financing Annual Activity Cr 688
Net Cash Flow Annual Cr -2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 2,196
Fixed Assets Annual Cr 2,258
Total Non Current Assets Annual Cr 2,903
Total Current Assets Annual Cr 765
Total Assets Annual Cr 3,667
IndicatorMar 2023
Book Value Per Share Annual Rs 163
ROE Annual % 17
ROCE Annual % 13
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 33

Eris Lifesciences Technicals

EMA & SMA

Current Price
₹875.5
7.25 (0.84%)
pointer
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹885.81
  • 50 Day
  • ₹892.83
  • 100 Day
  • ₹876.97
  • 200 Day
  • ₹829.71
  • 20 Day
  • ₹892.73
  • 50 Day
  • ₹897.25
  • 100 Day
  • ₹894.76
  • 200 Day
  • ₹814.75

Eris Lifesciences Resistance and Support

PIVOT
₹864.65
Resistance
First Resistance 878.35
Second Resistance 888.45
Third Resistance 902.15
RSI 44.62
MFI 39.94
MACD Single Line -6.25
MACD -10.93
Support
First Resistance 854.55
Second Resistance 840.85
Third Resistance 830.75

Eris Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 146,441 9,774,937 66.75
Week 221,894 9,940,842 44.8
1 Month 517,810 31,705,527 61.23
6 Month 208,269 10,675,850 51.26

Eris Lifesciences Result Highlights

Eris Lifesciences Synopsis

NSE-Medical-Biomed/Biotech

Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1330.73 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2023. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.
Market Cap 11,922
Sales 1,460
Shares in Float 6.12
No of funds 126
Yield
Book Value 5.31
U/D Vol ratio 0.9
LTDebt / Equity 9
Alpha 0.08
Beta 0.47

Eris Lifesciences

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 54.9%54.91%52.86%52.86%
Mutual Funds 13.85%13.86%10.27%9.64%
Insurance Companies 0.01%
Foreign Portfolio Investors 13.13%13.2%13.78%14.86%
Financial Institutions/ Banks
Individual Investors 15.67%15.47%22.07%21.66%
Others 2.45%2.56%1.01%0.98%

Eris Lifesciences Management

Name Designation
Mr. Amit Bakshi Chairperson & Managing Director
Mr. Krishnakumar Vaidyanathan COO & Executive Director
Mr. Inderjeet Singh Negi Executive Director
Mr. Kaushal Shah Executive Director
Mr. Rajeev Dalal Independent Director
Mr. Vasudevan Sujesh Independent Director
Ms. Kalpana Unadkat Independent Director
Mr. Prashant Gupta Independent Director

Eris Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eris Lifesciences Corporate Action

Date Purpose Remarks
2024-02-13 Quarterly Results
2023-11-08 Quarterly Results
2023-08-07 Quarterly Results
2023-05-17 Audited Results
2023-01-17 Quarterly Results
Date Purpose Remarks
2022-08-16 INTERIM Rs.7.35 per share(735%)Interim Dividend
2021-08-06 INTERIM Rs.6.01 per share(601%)Interim Dividend

Eris Lifesciences FAQs

What is Share Price of Eris Lifesciences ?

Eris Lifesciences share price is ₹875 As on 23 February, 2024 | 16:42

What is the Market Cap of Eris Lifesciences ?

The Market Cap of Eris Lifesciences is ₹11909.3 Cr As on 23 February, 2024 | 16:42

What is the P/E ratio of Eris Lifesciences ?

The P/E ratio of Eris Lifesciences is 30.8 As on 23 February, 2024 | 16:42

What is the PB ratio of Eris Lifesciences ?

The PB ratio of Eris Lifesciences is 5.4 As on 23 February, 2024 | 16:42

Q2FY23